Suman Basavaraju

Suman Basavaraju

Auto-generated profile, based on publicly available information

Suman Basavaraju

Department of Periodontology, JSS Dental College and Hospital, JSS Academy of Higher Education and Research, Mysuru, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2023 in Journal of Advanced Periodontology & Implant Dentistry
Verified
Journal Article
Open access
PDF file
VHVeena HR
Veena HR
RDRiya Achamma Daniel
Riya Achamma Daniel
APAshwin Prabhu
Ashwin Prabhu
SPShilpa P
Shilpa P
SBSuman Basavaraju
Suman Basavaraju
Background. Long-term use of many classic chemotherapeutic agents as adjuncts in the management of periodontitis has adverse complications, leading to seeking out naturopathic remedies. Although curcumin has been investigated in managing periodontitis, its therapeutic benefits have not been fully explored due to its limited solubility in an aqueous medium. This study aimed to develop a novel target-specific drug delivery system containing 1% self-nanoemulsifying curcumin (SNEC) in a hydroxypropylmethylcellulose (HPMC) matrix and evaluate the susceptibility of periodontal pathogens to this system in vitro. Methods. Its antibacterial activity against Tannerella forsythia, Porphyromonas gingivalis, Prevotella intermedia, and Aggregatibacter actinomycetemcomitans was evaluated and compared to pure nano-curcumin and SNEC alone by estimating their minimum inhibitory concentrations (MIC). Results. The antibacterial activity of pure nano-curcumin, SNEC, and SNEC in HPMC against the four periodontal pathogens evaluated in terms of MIC was recorded in the range of 0.2‒0.4, 0.4‒0.8, and 0.2‒0.8 µg/mL, respectively. However, the MIC of all three curcumin formulations against the periodontal pathogens tested was higher than that of the standard moxifloxacin. While both pure nano-curcumin and SNEC showed increasing values of inhibition zones with increasing concentrations on disk diffusion assay, lower concentrations of SNEC in HPMC did not show a zone of inhibition against the tested pathogens. Conclusion. The novel delivery system containing SNEC in HPMC may be a potential adjunct in managing periodontitis due to its probable sustained antimicrobial activity against the tested periodontal pathogens.

30 December 2024 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
PRPremalatha B. R
Premalatha B. R
SBSuman Basavaraju
Suman Basavaraju
SubbaRao V. MadhunapantulaSubbaRao V. Madhunapantula
SubbaRao V. Madhunapantula
HSHemanth Kumar S
Hemanth Kumar S
VRVeena H. R
Veena H. R
UHUsha Hegde
Usha Hegde
Objective: This scoping review is aimed at evaluating the therapeutic potential of luteolin in periodontal therapy. Introduction: Periodontal disease is a destructive, inflammatory process of the tooth-supporting tissues resulting frequently in tooth loss. Current periodontal therapy includes surgical and non-surgical strategies. Plant-based adjuvant therapies have recently gained popularity due to their potent pharmacological qualities and negligible side effects. Luteolin is a flavonoid found in many herbs, vegetables, and fruits. It exhibits several biological activities useful in fighting periodontal diseases. Considering luteolin’s promising biological properties, its anti-periodontal disease potential needs further investigation. In this article, we present the protocol of the planned scoping review which will map currently available research on luteolin’s therapeutic potential in periodontal disease management. Methods: The scoping review is planned to be performed as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines (PRISMA-ScR). This review will include any study design in English that investigates the effects of luteolin in periodontal disease management. No date restrictions will be applied. A comprehensive literature review will be executed by screening relevant electronic databases such as PubMed, Scopus, and Web of Science as well as grey literature and hand screening of pertinent article reference lists and citations. A three-step synthesis process will be employed. Screening of the articles will be conducted by qualified reviewers who will extract information into a predesigned data collection instrument. Results: We shall present the data in tabular format along with the narrative summary. Conclusion: Our proposed scoping review will outline the biological properties of luteolin that are beneficial in periodontal therapy and identify gaps in the scientific literature that require further research.

1 January 2024 in Journal of Oral Research
Verified
Journal Article
Closed access
SBSuman Basavaraju
Suman Basavaraju
DHDhakshaini
Dhakshaini
AYAnshukumar Yadav
Anshukumar Yadav
VHVeena HR
Veena HR
RDRiya Achamma Daniel
Riya Achamma Daniel
Background: The therapeutic use of gingival mesenchymal stem cells (GMSCs) as autologous cells may pose the challenge of alterations inflicted by the hyperglycemic environment. Objective: This study aims to assess the effects of hyperglycemia on the characteristics of GMSCs in diabetics. Materials and Methods: 10 patients who consented and fulfilled the criteria for inclusion and exclusion were recruited and categorized as test (HbA1c > 6.5) and control (HbA1c < 6.0). Gingival explants were obtained from gingival collar of teeth, washed, digested and cultured. The cells were subjected to microscopic observation to assess phenotype characteristics, and flow cytometry and qRT-PCR to assess differentiation potential. Stem cell markers CD90, CD73, CD105, CD34, CD45, HLA DR & HLA ABC, osteogenic differentiation markers RUNX2 & OCN, adipogenic differentiation markers PPARG2 & FABP4 and chondrogenic differentiation markers SOX9 & AGCN were evaluated. Results: Microscopic appearance of spindle shaped cells was found to be comparable in both groups. Flow cytometry results demonstrated comparable expressions with both groups, samples being positive for CD90, CD73, CD105, HLA ABC and negative for CD34, CD45 & HLA DR. There were variations in the expression of markers when assessed for differentiation potentials. Conclusions: The hyperglycemic environment did not manifest any changes in the phenotypic characteristics of GMSCs among diabetics. However, the expression of certain differentiation markers was significantly altered in the diabetic test population included. Further research is being conducted to understand the GMSCs in a hyperglycemic environment with an aim to develop strategies to optimize its clinical implications.